Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
TREATMENT OF CANCER WITH A SEMAPHORIN-4D ANTIBODY IN COMBINATION WITH AN EPIGENETIC MODULATING AGENT
No-Receipt date
2023-03722 - 03/11/2023
No-Filing date
20230402092 - 03/11/2023
No-Granting date
3113786 - 17/11/2023
No-EPO application date
18771465.4 - 14/03/2018
No-EPO granting date
3600419 - 09/08/2023
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
11/2023 - 11/12/2023
Expiration date
15/03/2038
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
US201762473731 P20/03/2017/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
C07K 16/28
A61P 35/00
A61K 45/06
A61K 39/395
A61K 31/7068
A61K 31/4406
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1542944
VACCINEX, INC.
1895 MT. HOPE AVENUE
ROCHESTER, NY 14620
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
4004303
EVANS, ELIZABETH
4004304
SMITH, ERNEST S.
4004305
ZAUDERER, MAURICE
Representatives
Code
Firstname
Surname
Address
Town
Zip
3463
MARIA
ATHANASIADOU "ELENI G. PAPAKONSTANTINOU KAI SYNERGATES, DIKIGORIKI ETAIRIA"
KOUMPARI 2
ATHINA (ATTIKIS)
10674
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
848
EFANGELIA
GIAZITZOGLOU - THOMAIDOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
GREECE
Owners History
Title Instruments
Payments history
8 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).